Condition
Neurovascular Disorder
Total Trials
6
Recruiting
1
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (4)
P 3 (1)
Trial Status
Completed2
Unknown2
Active Not Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT06752096Not ApplicableRecruiting
Robot-Assisted Neurovascular Intervention
NCT04888221Phase 3Active Not Recruiting
Efficacy of Tocilizumab in Association to Steroids in Giant Cell Arteritis With Cerebro-vascular Involvement
NCT04568161Not ApplicableCompleted
Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses
NCT06189378Not ApplicableCompletedPrimary
Adherence to Blood Pressure Diaries With Personalized Visuals
NCT04865718Unknown
Intraoperative Laser Speckle Contrast Imaging of Cerebral Blood Flow
NCT04537611Not ApplicableUnknown
Deoxyhemoglobin Concentration Changes and Cerebral Perfusion Imaging
Showing all 6 trials